Cargando…
Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012
To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454113/ https://www.ncbi.nlm.nih.gov/pubmed/32818392 http://dx.doi.org/10.3201/eid2609.190524 |
_version_ | 1783575464316502016 |
---|---|
author | Ramsay, Lauren C. Shing, Emily Wang, John Marras, Theodore K. Kwong, Jeffrey C. Brode, Sarah K. Jamieson, Frances B. Sander, Beate |
author_facet | Ramsay, Lauren C. Shing, Emily Wang, John Marras, Theodore K. Kwong, Jeffrey C. Brode, Sarah K. Jamieson, Frances B. Sander, Beate |
author_sort | Ramsay, Lauren C. |
collection | PubMed |
description | To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients with incident NTM-PD and NTM-PI during 2001–2012 by using individually linked laboratory data and health administrative data, matched to unexposed persons from the general population. To estimate attributable costs for acute and long-term illness, we used a phase-of-care approach. Costs were stratified by age, sex, and healthcare resource, and reported in 2018 Canadian dollars (CAD) and US dollars (USD), standardized to 10 days. Costs were highest during the before-death phase (NTM-PD CAD $1,352 [USD $1,044]; NTM-PI CAD $731 [USD $565]). The cumulative mean attributable 1-year costs were CAD $14,953 (USD $11,541) for NTM-PD and CAD $8,729 (USD $6,737) for NTM-PI. Costs for patients with NTM-PD and NTM-PI were higher than those for unexposed persons. |
format | Online Article Text |
id | pubmed-7454113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-74541132020-09-03 Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 Ramsay, Lauren C. Shing, Emily Wang, John Marras, Theodore K. Kwong, Jeffrey C. Brode, Sarah K. Jamieson, Frances B. Sander, Beate Emerg Infect Dis Research To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in Ontario, Canada. We established cohorts of patients with incident NTM-PD and NTM-PI during 2001–2012 by using individually linked laboratory data and health administrative data, matched to unexposed persons from the general population. To estimate attributable costs for acute and long-term illness, we used a phase-of-care approach. Costs were stratified by age, sex, and healthcare resource, and reported in 2018 Canadian dollars (CAD) and US dollars (USD), standardized to 10 days. Costs were highest during the before-death phase (NTM-PD CAD $1,352 [USD $1,044]; NTM-PI CAD $731 [USD $565]). The cumulative mean attributable 1-year costs were CAD $14,953 (USD $11,541) for NTM-PD and CAD $8,729 (USD $6,737) for NTM-PI. Costs for patients with NTM-PD and NTM-PI were higher than those for unexposed persons. Centers for Disease Control and Prevention 2020-09 /pmc/articles/PMC7454113/ /pubmed/32818392 http://dx.doi.org/10.3201/eid2609.190524 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Ramsay, Lauren C. Shing, Emily Wang, John Marras, Theodore K. Kwong, Jeffrey C. Brode, Sarah K. Jamieson, Frances B. Sander, Beate Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title | Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title_full | Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title_fullStr | Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title_full_unstemmed | Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title_short | Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001–2012 |
title_sort | costs associated with nontuberculous mycobacteria infection, ontario, canada, 2001–2012 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454113/ https://www.ncbi.nlm.nih.gov/pubmed/32818392 http://dx.doi.org/10.3201/eid2609.190524 |
work_keys_str_mv | AT ramsaylaurenc costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT shingemily costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT wangjohn costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT marrastheodorek costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT kwongjeffreyc costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT brodesarahk costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT jamiesonfrancesb costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 AT sanderbeate costsassociatedwithnontuberculousmycobacteriainfectionontariocanada20012012 |